Evaluate the Safety and Efficacy of FG-3019 (Pamrevlumab) in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Anish Ambaram, M.D.
Life Mount Edgecombe Hospital, South Africa
Principal Investigator - Benedict Brockway, M.D.
Dunedin Public Hospital, New Zealand
Principal Investigator - Bhanu Singh, M.D.
Midland Healthcare & Research Center, India
Principal Investigator - Catherina Chang, M.D.
Waikato Hospital, New Zealand
Principal Investigator - Danielle Antin-Ozerkis, M.D.
Yale University, USA
Principal Investigator - Danielle D. Hosmer
Legacy Research Institute, USA
Principal Investigator - David Lederer, M.D.
Columbia University Medical Center, USA
Principal Investigator - Elizabeth Veitch, M.D.
Concord Repatriation, Australia
Principal Investigator - Elvis Irusen, M.D.
Tygerberg Hospital Respiratory Research Unit, South Africa
Principal Investigator - Evans R Fernandez-Perez, M.D
National Jewish Center, USA
Principal Investigator - Heidi Siebert, M.D.
Into Research, South Africa
Principal Investigator - Huw Davies, M.D.
Daw Park Repatriation, Australia
Principal Investigator - James Britt, M.D.
University of Maryland, College Park
Principal Investigator - Joao de Andrade, M.D
The Kirklin Clinic, USA
Principal Investigator - John Fitzgerald, M.D.
University of Texas Southwestern Medical Center, USA
Principal Investigator - Kevin Gibson, M.D
University of Pittsburgh Medical Center, USA
Principal Investigator - Krishna Thavarajah, M.D.
Henry Ford Medical Center, USA
Principal Investigator - Lutz Beckert, M.D.
Christchurch Hospital NZ, New Zealand
Principal Investigator - Mark Hamblin, M.D.
University of Kansas Medical Center, USA
Principal Investigator - Mark Wencel, M.D
Via Christi Clinic, P.A., USA
Principal Investigator - Mary Beth Scholand, M.D.
University of Utah - Lung Health Research, USA
Principal InvestigatorKOL profile → - Murali Ramaswamy, M.D.
PulmonIx LLC, USA
Principal Investigator - Nadim Srour, M.D.
Université de Sherbrooke / Hôpital Charles LeMoyne, Canada
Principal Investigator - Nandagopal Velayuthaswamy, M.D.
Sri Bala Medical Centre and Hospital, India
Principal Investigator - Natalia Stoeva, M.D.
MHAT 'Tokuda Hospital Sofia', AD, Department of Pulmonology, Bulgaria
Principal Investigator - Neil Ettinger, M.D
St Luke's Hospital, USA
Principal Investigator - Nishant Gupta, M.D
University of Cinncinati, USA
Principal Investigator - Peter A Bercz, M.D
Pensacola Research Consultants, INC., USA
Principal Investigator - Peter LaCamera, M.D.
Steward St. Elizabeth's Medical Center, USA
Principal Investigator - Priya Ramachandran, M.D.
St Johns Medical College Hospital, India
Principal Investigator - Rafael Perez, M.D
University of Louisville, USA
Principal Investigator - Raja Dhar, M.D.
Fortis Hospitals, India
Principal Investigator - Richard Enelow, M.D.
Dartmouth-Hitchcock Medical Center, USA
Principal Investigator - Rishi Raj, M.D.
Northwestern University
Principal Investigator - Srihari Veeraraghavan, M.D
Emory University, USA
Principal Investigator - Sujeet Rajan, M.D.
Bhatia Hospital, India
Principal Investigator - Suzanne Poole, M.D.
Tauranga Hospital, New Zealand
Principal Investigator - Thomas O'Brien, M.D.
Pulmonary Disease Specialist, PA, USA
Principal Investigator - Timothy Albertson, M.D
University of California Davis Medical Center, USA
Principal Investigator - Yolanda Mageto, M.D.
Vermont Lung Center, USA
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
42 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Concord Repatriation
Concord, New South Wales, Australia
- Daw Park Repatriation
Adelaide, South Australia, Australia
- Mhat 'Tokuda Hospital Sofia', Ad, Department of Pulmonology
Sofia, Bulgaria
- Université de Sherbrooke / Hôpital Charles Lemoyne
Greenfield Park, Quebec, Canada
- St Johns Medical College Hospital
Bangalore, Karnataka, India
- Bhatia Hospital
Mumbai, Maharashtra, India
- Sri Bala Medical Centre and Hospital
Coimbatore, Tamil Nadu, India
- Midland Healthcare & Research Center
Lucknow, Uttar Pradesh, India
- Fortis Hospitals
Kolkata, West Bengal, India
- Christchurch Hospital Nz
Christchurch, New Zealand
- Dunedin Public Hospital
Dunedin, New Zealand
- Waikato Hospital
Hamilton, New Zealand
- Tauranga Hospital
Tauranga, New Zealand
- Into Research
Pretoria, Gauteng, South Africa
- Life Mount Edgecombe Hospital
Durban, KwaZulu-Natal, South Africa
- Tygerberg Hospital Respiratory Research Unit
Cape Town, Western Cape, South Africa
- the Kirklin Clinic
Birmingham, Alabama, United States
- David Geffen School of Medicine at Ucla
Los Angeles, California, United States
- Uc Davis Medical Center
Sacramento, California, United States
- National Jewish Health
Denver, Colorado, United States
- Yale University
New Haven, Connecticut, United States
- Pulmonary Disease Specialist, Pa
Kissimmee, Florida, United States
- Pensacola Research Consultants, Inc., D.B.A. Avanza Medical Research Center
Pensacola, Florida, United States
- Emory University
Atlanta, Georgia, United States
- Northwestern University
Chicago, Illinois, United States
- University of Kansas Medical Center
Kansas City, Kansas, United States
- Via Christi Clinic, P.A.
Wichita, Kansas, United States
- University of Louisville
Louisville, Kentucky, United States
- University of Maryland
Baltimore, Maryland, United States
- Steward St. Elizabeth'S Medical Center
Boston, Massachusetts, United States
- Henry Ford Medical Center
Detroit, Michigan, United States
- St. Luke'S Hospital
Chesterfield, Missouri, United States
- Columbia University Medical Center
New York, New York, United States
- Pulmonix Llc
Greensboro, North Carolina, United States
- University of Cinncinati
Cincinnati, Ohio, United States
- Dartmouth-Hitchcock Medical Center
Lebanon, Ohio, United States
- Legacy Research Institute
Portland, Oregon, United States
- University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
- Vanderbilt University
Nashville, Tennessee, United States
- University of Texas Southwestern Medical Center
Dallas, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jul 2013
- Primary completion
- 16 Nov 2017
- Completion
- 16 Nov 2017
- Last update posted
- 4 Sept 2020
- Registered enrollment
- 160
- Registry id
- NCT01890265
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.